NSRX
Nasus Pharma Ltd. Ordinary Shares (NSRX)
$65
About Nasus Pharma Ltd. Ordinary Shares (NSRX)
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel.
Details
Daily high
$3.75
Daily low
$3.37
Price at open
$3.65
52 Week High
$9.99
52 Week Low
$1.98
Market cap
43.3M
Dividend yield
-
Volume
18,690
Avg. volume
14,417
P/E ratio
-19.17
Nasus Pharma Ltd. Ordinary Shares News
Details
Daily high
$3.75
Daily low
$3.37
Price at open
$3.65
52 Week High
$9.99
52 Week Low
$1.98
Market cap
43.3M
Dividend yield
-
Volume
18,690
Avg. volume
14,417
P/E ratio
-19.17